DK1179014T3 - Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII - Google Patents
Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIIIInfo
- Publication number
- DK1179014T3 DK1179014T3 DK00921293T DK00921293T DK1179014T3 DK 1179014 T3 DK1179014 T3 DK 1179014T3 DK 00921293 T DK00921293 T DK 00921293T DK 00921293 T DK00921293 T DK 00921293T DK 1179014 T3 DK1179014 T3 DK 1179014T3
- Authority
- DK
- Denmark
- Prior art keywords
- domain
- spa
- derivatives
- factor viii
- human factor
- Prior art date
Links
- 108010088160 Staphylococcal Protein A Proteins 0.000 title abstract 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title abstract 2
- 102000057593 human F8 Human genes 0.000 title abstract 2
- 229960000900 human factor viii Drugs 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901379A SE9901379D0 (sv) | 1999-04-19 | 1999-04-19 | Receptor structures |
| PCT/SE2000/000732 WO2000063243A1 (en) | 1999-04-19 | 2000-04-17 | Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1179014T3 true DK1179014T3 (da) | 2009-04-06 |
Family
ID=20415254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00921293T DK1179014T3 (da) | 1999-04-19 | 2000-04-17 | Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1179014B1 (da) |
| JP (1) | JP4578690B2 (da) |
| AT (1) | ATE417058T1 (da) |
| AU (1) | AU4162400A (da) |
| DE (1) | DE60041052D1 (da) |
| DK (1) | DK1179014T3 (da) |
| SE (1) | SE9901379D0 (da) |
| WO (1) | WO2000063243A1 (da) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002056024A2 (en) * | 2001-01-12 | 2002-07-18 | Affibody Ab | Detection methods |
| EP1504265B1 (en) * | 2002-04-29 | 2011-11-30 | Affibody AB | Sandwich assay |
| AU2003244817B2 (en) * | 2002-06-28 | 2010-08-26 | Domantis Limited | Antigen-binding immunoglobulin single variable domains and dual-specific constructs |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| SE0301936D0 (sv) * | 2003-06-30 | 2003-06-30 | Affibody Ab | New polypeptide |
| CA2531238C (en) * | 2003-07-04 | 2015-02-24 | Affibody Ab | Polypeptides having binding affinity for her2 |
| SE0301987D0 (sv) * | 2003-07-04 | 2003-07-04 | Affibody Ab | New polypeptide |
| GB0524788D0 (en) | 2005-12-05 | 2006-01-11 | Affibody Ab | Polypeptides |
| EP2099932A4 (en) | 2006-12-06 | 2009-11-18 | Repligen Corp | NUCLEIC ACIDS ENCODING THE RECOMBINANT PROTEIN A |
| US7981691B2 (en) | 2006-12-08 | 2011-07-19 | General Electric Company | Two helix binders |
| US7977118B2 (en) | 2006-12-08 | 2011-07-12 | General Electric Company | Two helix binders |
| US8198043B2 (en) | 2006-12-08 | 2012-06-12 | General Electric Company | Two helix binders |
| US7989216B2 (en) | 2006-12-08 | 2011-08-02 | General Electric Company | Two helix binders |
| RU2009137582A (ru) | 2007-03-12 | 2011-04-20 | Эсбатек Аг (Ch) | Инженерия и оптимизация одноцепочечных антител на основе последовательности |
| BRPI0813645A2 (pt) | 2007-06-25 | 2014-12-30 | Esbatech Alcon Biomed Res Unit | Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas |
| EP2164961B1 (en) | 2007-06-25 | 2015-01-07 | ESBATech, an Alcon Biomedical Research Unit LLC | Sequence based engineering and optimization of single chain antibodies |
| WO2009019117A1 (en) * | 2007-08-03 | 2009-02-12 | Affibody Ab | Igf-1r binding polypeptides and their use |
| GB2453589A (en) | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
| CA2728829C (en) | 2008-06-25 | 2018-01-02 | Esbatech, An Alcon Biomedical Research Unit Llc | Solubility optimization of immunobinders |
| US8592555B2 (en) | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
| AU2009282413B2 (en) | 2008-08-11 | 2014-07-17 | Nektar Therapeutics | Multi-arm polymeric alkanoate conjugates |
| WO2010021720A1 (en) | 2008-08-19 | 2010-02-25 | Nektar Therapeutics | Conjugates of small-interfering nucleic acids |
| SG195555A1 (en) | 2008-12-24 | 2013-12-30 | Emd Millipore Corp | Caustic stable chromatography ligands |
| CA2791918C (en) | 2010-03-05 | 2019-11-19 | Boehringer Ingelheim International Gmbh | Selective enrichment of antibodies |
| TW201217527A (en) | 2010-07-09 | 2012-05-01 | Biogen Idec Hemophilia Inc | Processable single chain molecules and polypeptides made using same |
| WO2012088445A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| WO2012088422A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| US20140088021A1 (en) | 2011-05-27 | 2014-03-27 | Nektar Therapeutics | Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds |
| SG186552A1 (en) | 2011-06-08 | 2013-01-30 | Emd Millipore Corp | Chromatography matrices including novel staphylococcus aureus protein a based ligands |
| ES2893855T3 (es) | 2011-08-11 | 2022-02-10 | Ono Pharmaceutical Co | Agente terapéutico para enfermedades autoinmunes que comprende agonista de PD-1 |
| US9676849B2 (en) | 2012-01-10 | 2017-06-13 | Biogen Ma Inc. | Enhancement of transport of therapeutic molecules across the blood brain barrier |
| WO2013175276A1 (en) | 2012-05-23 | 2013-11-28 | Argen-X B.V | Il-6 binding molecules |
| WO2014103203A1 (ja) | 2012-12-27 | 2014-07-03 | 独立行政法人産業技術総合研究所 | 微小タンパク質の骨格構造に基づく分子ライブラリ |
| EP3019520B1 (en) | 2013-07-10 | 2019-12-11 | GE Healthcare BioProcess R&D AB | Mutated immunoglobulin-binding polypeptides |
| MX367423B (es) * | 2013-08-28 | 2019-08-21 | Affibody Ab | Polipeptidos de union a c5. |
| WO2020221781A1 (en) | 2019-04-29 | 2020-11-05 | Cytiva Bioprocess R&D Ab | Method for separation of antibodies or antibody fragments being devoid of an fc region capable of binding to protein a |
| JP6881658B2 (ja) | 2019-07-05 | 2021-06-02 | 小野薬品工業株式会社 | Pd−1/cd3二重特異性タンパク質による血液がん治療 |
| US20220332825A1 (en) | 2019-08-08 | 2022-10-20 | Ono Pharmaceutical Co., Ltd. | Bispecific protein |
| US20230399375A1 (en) | 2022-04-15 | 2023-12-14 | Kyverna Therapeutics, Inc. | Methods and compositions for treating autoimmune disease |
| WO2023212704A2 (en) * | 2022-04-29 | 2023-11-02 | Tezcat Biosciences, Inc. | Macropinocytosis selective non-binding protein-drug conjugates |
| US20250223326A1 (en) | 2022-05-10 | 2025-07-10 | Institut National de la Santé et de la Recherche Médicale | Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells |
| WO2025041077A1 (en) | 2023-08-23 | 2025-02-27 | Sanofi | Ctla-4-based lysosomal degraders and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI86885C (fi) | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
| SE8501050D0 (sv) | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
| SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
| SE468050C (sv) | 1991-03-15 | 1998-04-27 | Pharmacia & Upjohn Ab | Rekombinant derivat av human faktor VIII |
| SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
-
1999
- 1999-04-19 SE SE9901379A patent/SE9901379D0/xx unknown
-
2000
- 2000-04-17 DK DK00921293T patent/DK1179014T3/da active
- 2000-04-17 AU AU41624/00A patent/AU4162400A/en not_active Abandoned
- 2000-04-17 WO PCT/SE2000/000732 patent/WO2000063243A1/en not_active Ceased
- 2000-04-17 DE DE60041052T patent/DE60041052D1/de not_active Expired - Lifetime
- 2000-04-17 AT AT00921293T patent/ATE417058T1/de not_active IP Right Cessation
- 2000-04-17 JP JP2000612330A patent/JP4578690B2/ja not_active Expired - Lifetime
- 2000-04-17 EP EP00921293A patent/EP1179014B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4578690B2 (ja) | 2010-11-10 |
| JP2002542259A (ja) | 2002-12-10 |
| WO2000063243A1 (en) | 2000-10-26 |
| EP1179014A1 (en) | 2002-02-13 |
| DE60041052D1 (de) | 2009-01-22 |
| AU4162400A (en) | 2000-11-02 |
| EP1179014B1 (en) | 2008-12-10 |
| ATE417058T1 (de) | 2008-12-15 |
| SE9901379D0 (sv) | 1999-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1179014T3 (da) | Derivater af Z-domænet fra staphylococcalt protein A (SPA), som interagerer med mindst ét domæne fra human faktor VIII | |
| EP2292273A3 (en) | Remodeling and glycoconjugation of peptides | |
| DE60141546D1 (de) | Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB | |
| ATE368053T1 (de) | Antimikrobielle peptide | |
| SI1346034T1 (sl) | POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| DK1451224T3 (da) | Peptid eller protein, der indeholder en C´-D-sløjfe fra CD28-receptorfamilien | |
| ATE193022T1 (de) | Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin | |
| FI972384A7 (fi) | Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-termin aalisia sulfonyyli- tai amidinosulfonyyliryhmiä | |
| GB0110430D0 (en) | Protein variants and uses thereof | |
| DK1908772T3 (da) | Polypeptider og polynucleinsyrer af phorphorymonas gingivalis | |
| ATE356140T1 (de) | Gd3 mimetische peptide | |
| NO951418D0 (no) | Peptidderivater, deres fremstilling og anvendelse som terapeutika | |
| CY1109946T1 (el) | Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων | |
| SE9003374D0 (sv) | A collagen binding protein as well as its preparation | |
| ATE550345T1 (de) | Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren | |
| ATE385805T1 (de) | Neue peptide | |
| NO20014130D0 (no) | Epitoper eller mimotoper avledet fra C-<epsilon>2-domenet hos IgE, antagonister derav og deres terapeutiske anvendelser | |
| SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
| NO975130D0 (no) | <alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1-piperidinbutanolderivater, deres fremstilling og deres anvendelse som antihistaminer, anti-allergimidler og bronchodilatorer | |
| DK1189615T3 (da) | Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner | |
| DE69122103D1 (de) | Antigerinnungspeptide | |
| DK0938555T3 (da) | Konstruktioner og komplekser af cyclin E | |
| DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
| ATE278712T1 (de) | Antikörper gegen plazentaprotein 13 |